Kenneth Alan Bauer | Profiles RNS

Kenneth Alan Bauer, MD

Adjunct Professor

Boston University Chobanian & Avedisian School of Medicine

Medicine

Hematology & Medical Oncology

MD, Stanford University School of Medicine
MS, Massachusetts Institute of Technology
BS, Massachusetts Institute of Technology

Websites

	Harvard Catalyst
	BIDMC
	BUMC
	Linkedin
	ResearchGate
	Beth Israel Lahey Health Profile
	Beth Israel and Harvard Med Profile

VA Boston Healthcare System

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis Copy PMIDs To Clipboard

Ryu J, Rämö JT, Jurgens SJ, Niiranen T, Sanna-Cherchi S, Bauer KA, Haj A, Choi SH, Palotie A, Daly M, Ellinor PT, Bendapudi PK. Thrombosis risk in single- and double-heterozygous carriers of factor V Leiden and prothrombin G20210A in FinnGen and the UK Biobank. Blood. 2024 Jun 06; 143(23):2425-2432. PMID: 38498041

Ryu JH, Bauer KA, Schulman S. Periprocedural management of type 2N von Willebrand disease with efanesoctocog alfa. J Thromb Haemost. 2023 Dec; 21(12):3508-3510. PMID: 37734716

Liu J, Elsamadisi P, Philips E, Bauer KA, Eche IM. Four-factor prothrombin complex concentrate plus andexanet alfa for reversal of factor Xa inhibitor-associated bleeding: Case series. Am J Health Syst Pharm. 2022 08 05; 79(16):1323-1329. PMID: 35291008

Sharda AV, Fatovic K, Bauer KA. Aspirin thromboprophylaxis in joint replacement surgery. Res Pract Thromb Haemost. 2022 Jan; 6(1):e12649. PMID: 35106432; PMCID: PMC8785144; DOI: 10.1002/rth2.12649;

Al-Samkari H, Gupta S, Leaf RK, Wang W, Rosovsky RP, Brenner SK, Hayek SS, Berlin H, Kapoor R, Shaefi S, Melamed ML, Sutherland A, Radbel J, Green A, Garibaldi BT, Srivastava A, Leonberg-Yoo A, Shehata AM, Flythe JE, Rashidi A, Goyal N, Chan L, Mathews KS, Hedayati SS, Dy R, Toth-Manikowski SM, Zhang J, Mallappallil M, Redfern RE, Bansal AD, Short SAP, Vangel MG, Admon AJ, Semler MW, Bauer KA, Hernán MA, Leaf DE. Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19. Ann Intern Med. 2021 05; 174(5):622-632. PMID: 33493012; PMCID: PMC7863679; DOI: 10.7326/M20-6739;

Chiasakul T, Bauer KA. Thrombolytic therapy in acute venous thromboembolism. Hematology Am Soc Hematol Educ Program. 2020 12 04; 2020(1):612-618. PMID: 33275702; PMCID: PMC7727565; DOI: 10.1182/hematology.2020000148;

Patell R, Bogue T, Koshy A, Bindal P, Merrill M, Aird WC, Bauer KA, Zwicker JI. Postdischarge thrombosis and hemorrhage in patients with COVID-19. Blood. 2020 09 10; 136(11):1342-1346. PMID: 32766883; PMCID: PMC7483433; DOI: 10.1182/blood.2020007938;

Patell R, Bogue T, Bindal P, Koshy A, Merrill M, Aird WC, Bauer KA, Zwicker JI. Incidence of thrombosis and hemorrhage in hospitalized cancer patients with COVID-19. J Thromb Haemost. 2020 09; 18(9):2349-2357. PMID: 32692862; PMCID: PMC7405046; DOI: 10.1111/jth.15018;

Patell R, Khan AM, Bogue T, Merrill M, Koshy A, Bindal P, Joyce R, Aird WC, Neuberg D, Bauer KA, Zwicker JI. Heparin induced thrombocytopenia antibodies in Covid-19. Am J Hematol. 2020 Oct; 95(10):E295-E296. PMID: 32658337; PMCID: PMC7405086; DOI: 10.1002/ajh.25935;

Zwicker JI, Roopkumar J, Puligandla M, Schlechter BL, Sharda AV, Peereboom D, Joyce R, Bockorny B, Neuberg D, Bauer KA, Khorana AA. Dose-adjusted enoxaparin thromboprophylaxis in hospitalized cancer patients: a randomized, double-blinded multicenter phase 2 trial. Blood Adv. 2020 05 26; 4(10):2254-2260. PMID: 32442298; PMCID: PMC7252540; DOI: 10.1182/bloodadvances.2020001804;

Showing 10 of 208 results. Show More

Carroll BJ, Beyer SE, Mehegan T, Dicks A, Pribish A, Locke A, Godishala A, Soriano K, Kanduri J, Sack K, Raber I, Wiest C, Balachandran I, Marcus M, Chu L, Hayes MM, Weinstein JL, Bauer KA, Secemsky EA, Pinto DS. Changes in Care for Acute Pulmonary Embolism Through A Multidisciplinary Pulmonary Embolism Response Team. Am J Med. 2020 11; 133(11):1313-1321.e6. PMID: 32416175; PMCID: PMC8076889; DOI: 10.1016/j.amjmed.2020.03.058;

Kanjee Z, Bauer KA, Breu AC, Burns R. Should You Treat This Acutely Ill Medical Inpatient With Venous Thromboembolism Chemoprophylaxis?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center. Ann Intern Med. 2020 04 07; 172(7):484-491.View Related Profiles.

Breu, Anthony
Bauer, Kenneth Alan

PMID: 32252085

Moran J, Bauer KA. Managing thromboembolic risk in patients with hereditary and acquired thrombophilias. Blood. 2020 01 30; 135(5):344-350. PMID: 31917425

Bauer KA. How Effective and Safe Is Factor XI Inhibition in Preventing Venous Thrombosis? JAMA. 2020 01 14; 323(2):121-122. PMID: 31935013

Eche IM, Elsamadisi P, Wex N, Wyers MC, Brat GA, Cunningham K, Bauer KA. Intraoperative Unfractionated Heparin Unresponsiveness during Endovascular Repair of a Ruptured Abdominal Aortic Aneurysm following Administration of Andexanet Alfa for the Reversal of Rivaroxaban. Pharmacotherapy. 2019 08; 39(8):861-865. PMID: 31251821

Kearon C, Parpia S, Spencer FA, Schulman S, Stevens SM, Shah V, Bauer KA, Douketis JD, Lentz SR, Kessler CM, Connors JM, Ginsberg JS, Spadafora L, Julian JA. Long-term risk of recurrence in patients with a first unprovoked venous thromboembolism managed according to d-dimer results; A cohort study. J Thromb Haemost. 2019 07; 17(7):1144-1152. PMID: 31033194

Khorana AA, Soff GA, Kakkar AK, Vadhan-Raj S, Riess H, Wun T, Streiff MB, Garcia DA, Liebman HA, Belani CP, O'Reilly EM, Patel JN, Yimer HA, Wildgoose P, Burton P, Vijapurkar U, Kaul S, Eikelboom J, McBane R, Bauer KA, Kuderer NM, Lyman GH. Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer. N Engl J Med. 2019 02 21; 380(8):720-728. PMID: 30786186

Kearon C, Parpia S, Spencer FA, Baglin T, Stevens SM, Bauer KA, Lentz SR, Kessler CM, Douketis JD, Moll S, Kaatz S, Schulman S, Connors JM, Ginsberg JS, Spadafora L, Bhagirath V, Liaw PC, Weitz JI, Julian JA. Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolism. Blood. 2018 05 10; 131(19):2151-2160. PMID: 29490924; PMCID: PMC6536697; DOI: 10.1182/blood-2017-09-805689;

Carroll BJ, Pemberton H, Bauer KA, Chu LM, Weinstein JL, Levarge BL, Pinto DS. Initiation of a Multidisciplinary, Rapid Response Team to Massive and Submassive Pulmonary Embolism. Am J Cardiol. 2017 Oct 15; 120(8):1393-1398. PMID: 28807405

Bauer KA. The challenge of hospital-related thrombosis. Blood. 2017 07 13; 130(2):97-98. PMID: 28705852

Ganetsky M, Lopez G, Coreanu T, Novack V, Horng S, Shapiro NI, Bauer KA. Risk of Intracranial Hemorrhage in Ground-level Fall With Antiplatelet or Anticoagulant Agents. Acad Emerg Med. 2017 10; 24(10):1258-1266. PMID: 28475282

Stolla M, Chang S, Schulman S, Bauer K, Haspel R, Lerner AB. Use of thromboelastography in the management of a patient with acquired von Willebrand disease undergoing cardiac bypass surgery. Br J Haematol. 2018 04; 181(1):143-145. PMID: 28106909; DOI: 10.1111/bjh.14511;

Bauer KA, Nguyen-Cao TM, Spears JB. Issues in the Diagnosis and Management of Hereditary Antithrombin Deficiency. Ann Pharmacother. 2016 09; 50(9):758-67. PMID: 27281301

Bauer KA. Targeted Anti-Anticoagulants. N Engl J Med. 2015 Aug 06; 373(6):569-71. PMID: 26095632

Bauer KA. Current challenges in the management of hemophilia. Am J Manag Care. 2015 Mar; 21(6 Suppl):S112-22. PMID: 26168206

Kearon C, Spencer FA, O'Keeffe D, Parpia S, Schulman S, Baglin T, Stevens SM, Kaatz S, Bauer KA, Douketis JD, Lentz SR, Kessler CM, Moll S, Connors JM, Ginsberg JS, Spadafora L, Julian JA. D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study. Ann Intern Med. 2015 Jan 06; 162(1):27-34. PMID: 25560712

Zwicker JI, Bauer KA. How long is long enough? Extended anticoagulation for the treatment of cancer-associated deep vein thrombosis. J Clin Oncol. 2014 Nov 10; 32(32):3596-9. PMID: 25267753

Lubitz SA, Bauer KA, Benjamin EJ, Besdine RW, Forman DE, Gurol ME, Reddy VY, Singer DE. Stroke prevention in atrial fibrillation in older adults: existing knowledge gaps and areas for innovation: a summary of an American Federation for Aging research seminar. J Am Geriatr Soc. 2013 Oct; 61(10):1798-803.View Related Profiles.

Benjamin, Emelia
Bauer, Kenneth Alan

PMID: 24083473; PMCID: PMC3801265; DOI: 10.1111/jgs.12456;

Steinberg BA, Beckley PD, Deering TF, Clark CL, Amin AN, Bauer KA, Cryer B, Mansour M, Scheiman JM, Zenati MA, Newby LK, Peacock WF, Bhatt DL. Evaluation and management of the atrial fibrillation patient: a report from the Society of Cardiovascular Patient Care. Crit Pathw Cardiol. 2013 Sep; 12(3):107-15. PMID: 23892939

Bauer KA. Dabigatran, ROCKET atrial fibrillation, and beyond: basic science, mechanisms of agents, monitoring, and reversal. Stroke. 2013 Jun; 44(6 Suppl 1):S38-40. PMID: 23709725

James AH, Konkle BA, Bauer KA. Prevention and treatment of venous thromboembolism in pregnancy in patients with hereditary antithrombin deficiency. Int J Womens Health. 2013; 5:233-41. PMID: 23662090; PMCID: PMC3647601; DOI: 10.2147/IJWH.S43190;

Bauer KA. Pros and cons of new oral anticoagulants. Hematology Am Soc Hematol Educ Program. 2013; 2013:464-70. PMID: 24319220

Zwicker JI, Liebman HA, Bauer KA, Caughey T, Campigotto F, Rosovsky R, Mantha S, Kessler CM, Eneman J, Raghavan V, Lenz HJ, Bullock A, Buchbinder E, Neuberg D, Furie B. Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor-bearing microparticles: a randomized-controlled phase II trial (the Microtec study). Br J Haematol. 2013 Feb; 160(4):530-7. PMID: 23240761; PMCID: PMC3609903; DOI: 10.1111/bjh.12163;

Feinbloom D, Bauer KA. ACP Journal Club. Enoxaparin thrombophylaxis did not reduce mortality in acutely ill medical patients. Ann Intern Med. 2012 Apr 17; 156(8):JC4-06. PMID: 22508746

Bauer KA. Reversal of antithrombotic agents. Am J Hematol. 2012 May; 87 Suppl 1:S119-26. PMID: 22460529

Bauer KA. Recent progress in anticoagulant therapy: oral direct inhibitors of thrombin and factor Xa. J Thromb Haemost. 2011 Jul; 9 Suppl 1:12-9. PMID: 21781237

Battinelli EM, Bauer KA. Thrombophilias in pregnancy. Hematol Oncol Clin North Am. 2011 Apr; 25(2):323-33, viii. PMID: 21444033

Bauer KA. Long-term management of venous thromboembolism: a 61-year-old woman with unprovoked venous thromboembolism. JAMA. 2011 Apr 06; 305(13):1336-45. PMID: 21386068

Ken-Dror G, Drenos F, Humphries SE, Talmud PJ, Hingorani AD, Kivimäki M, Kumari M, Bauer KA, Morrissey JH, Ireland HA. Haplotype and genotype effects of the F7 gene on circulating factor VII, coagulation activation markers and incident coronary heart disease in UK men. J Thromb Haemost. 2010 Nov; 8(11):2394-403. PMID: 20735728; PMCID: PMC3226948; DOI: 10.1111/j.1538-7836.2010.04035.x;

Bauer KA, Gerson W, Wright C, Wang J, McNicol E, Lanier RK, Kramer W, Carr DB. Platelet function following administration of a novel formulation of intravenous diclofenac sodium versus active comparators: a randomized, single dose, crossover study in healthy male volunteers. J Clin Anesth. 2010 Nov; 22(7):510-8. PMID: 21056807

Lopaciuk S, Windyga J, Watala CW, Bykowska K, Pietrucha T, Kwiecinski H, Czlonkowska A, Kuczynska-Zardzewialy A, Jackson AA, Carew JA, Bauer KA. Polymorphisms in the factor VII gene and ischemic stroke in young adults. Blood Coagul Fibrinolysis. 2010 Jul; 21(5):442-7. PMID: 20453637

Bauer KA. Thrombophilia evaluation: the value of testing relatives. Clin Adv Hematol Oncol. 2010 Apr; 8(4):229-31. PMID: 20505643

Bauer KA. Duration of anticoagulation: applying the guidelines and beyond. Hematology Am Soc Hematol Educ Program. 2010; 2010:210-5. PMID: 21239796

Bauer KA. New oral anticoagulants in development: potential for improved safety profiles. Rev Neurol Dis. 2010; 7(1):1-8. PMID: 20410856

Zwicker JI, Liebman HA, Neuberg D, Lacroix R, Bauer KA, Furie BC, Furie B. Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy. Clin Cancer Res. 2009 Nov 15; 15(22):6830-40. PMID: 19861441; PMCID: PMC2783253; DOI: 10.1158/1078-0432.CCR-09-0371;

Ireland HA, Cooper JA, Drenos F, Acharya J, Mitchell JP, Bauer KA, Morrissey JH, Esnouf MP, Humphries SE. FVII, FVIIa, and downstream markers of extrinsic pathway activation differ by EPCR Ser219Gly variant in healthy men. Arterioscler Thromb Vasc Biol. 2009 Nov; 29(11):1968-74. PMID: 19696402; PMCID: PMC2775706; DOI: 10.1161/ATVBAHA.109.191551;

Turpie AG, Lassen MR, Davidson BL, Bauer KA, Gent M, Kwong LM, Cushner FD, Lotke PA, Berkowitz SD, Bandel TJ, Benson A, Misselwitz F, Fisher WD. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial. Lancet. 2009 May 16; 373(9676):1673-80. PMID: 19411100

Jackson D, White I, Kostis JB, Wilson AC, Folsom AR, Wu K, Chambless L, Benderly M, Goldbourt U, Willeit J, Kiechl S, Yarnell JW, Sweetnam PM, Elwood PC, Cushman M, Psaty BM, Tracy RP, Tybjaerg-Hansen A, Haverkate F, de Maat MP, Thompson SG, Fowkes FG, Lee AJ, Smith FB, Salomaa V, Harald K, Rasi V, Vahtera E, Jousilahti P, D'Agostino R, Kannel WB, Wilson PW, Tofler G, Levy D, Marchioli R, Valagussa F, Rosengren A, Wilhelmsen L, Lappas G, Eriksson H, Cremer P, Nagel D, Curb JD, Rodriguez B, Yano K, Salonen J, Nyyssönen K, Tuomainen TP, Hedblad B, Engström G, Berglund G, Loewel H, Koenig W, Hense HW, Meade TW, Cooper JA, De Stavola B, Knottenbelt C, Miller GJ, Cooper JA, Bauer KA, Rosenberg RD, Sato S, Kitamura A, Naito Y, Iso H, Salomaa V, Harald K, Rasi V, Vahtera E, Jousilahti P, Palosuo T, Ducimetiere P, Amouyel P, Arveiler D, Evans AE, Ferrieres J, Juhan-Vague I, Bingham A, Schulte H, Assmann G, Cantin B, Lamarche B, Despres JP, Dagenais GR, Tunstall-Pedoe H, Lowe GD, Woodward M, Ben-Shlomo Y, Davey Smith G, Palmieri V, Yeh JL, Meade TW, Rudnicka A, Brennan P, Knottenbelt C, Cooper JA, Ridker P, Rodeghiero F, Tosetto A, Shepherd J, Lowe GD, Ford I, Robertson M, Brunner E, Shipley M, Feskens EJ, Di Angelantonio E, Kaptoge S, Lewington S, Lowe GD, Sarwar N, Thompson SG, Walker M, Watson S, White IR, Wood AM, Danesh J. Systematically missing confounders in individual participant data meta-analysis of observational cohort studies. Stat Med. 2009 Apr 15; 28(8):1218-37.View Related Profiles.

Bauer, Kenneth Alan
D'Agostino, Ralph

PMID: 19222087; PMCID: PMC2922684; DOI: 10.1002/sim.3540;

Bezemer ID, Arellano AR, Tong CH, Rowland CM, Ireland HA, Bauer KA, Catanese J, Reitsma PH, Doggen CJ, Devlin JJ, Rosendaal FR, Bare LA. F9 Malmö, factor IX and deep vein thrombosis. Haematologica. 2009 May; 94(5):693-9. PMID: 19286883; PMCID: PMC2675682; DOI: 10.3324/haematol.2008.003020;

Turpie AG, Bauer KA, Davidson BL, Fisher WD, Gent M, Huo MH, Sinha U, Gretler DD. A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT). Thromb Haemost. 2009 Jan; 101(1):68-76. PMID: 19132191

Haspel J, Bauer K, Goehler A, Roberts DH. Long-term anticoagulant therapy for idiopathic pulmonary embolism in the elderly: a decision analysis. Chest. 2009 May; 135(5):1243-1251. PMID: 19017863

Fine G, Bauer K, Al-Mohaya M, Woo SB. Successful treatment of ligneous gingivitis with warfarin. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009 Jan; 107(1):77-80. PMID: 18996031

Bauer KA. New anticoagulants. Curr Opin Hematol. 2008 Sep; 15(5):509-15. PMID: 18695376

Hirsh J, Bauer KA, Donati MB, Gould M, Samama MM, Weitz JI. Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008 Jun; 133(6 Suppl):141S-159S. PMID: 18574264

Mueck W, Eriksson BI, Bauer KA, Borris L, Dahl OE, Fisher WD, Gent M, Haas S, Huisman MV, Kakkar AK, Kälebo P, Kwong LM, Misselwitz F, Turpie AG. Population pharmacokinetics and pharmacodynamics of rivaroxaban--an oral, direct factor Xa inhibitor--in patients undergoing major orthopaedic surgery. Clin Pharmacokinet. 2008; 47(3):203-16. PMID: 18307374

Freedman RA, Bauer KA, Neuberg DS, Zwicker JI. Timing of postpartum enoxaparin administration and severe postpartum hemorrhage. Blood Coagul Fibrinolysis. 2008 Jan; 19(1):55-9. PMID: 18180616

Miller GJ, Ireland HA, Cooper JA, Bauer KA, Morrissey JH, Humphries SE, Esnouf MP. Relationship between markers of activated coagulation, their correlation with inflammation, and association with coronary heart disease (NPHSII). J Thromb Haemost. 2008 Feb; 6(2):259-67. PMID: 17973650

Danesh J, Erqou S, Walker M, Thompson SG, Tipping R, Ford C, Pressel S, Walldius G, Jungner I, Folsom AR, Chambless LE, Knuiman M, Whincup PH, Wannamethee SG, Morris RW, Willeit J, Kiechl S, Santer P, Mayr A, Wald N, Ebrahim S, Lawlor DA, Yarnell JW, Gallacher J, Casiglia E, Tikhonoff V, Nietert PJ, Sutherland SE, Bachman DL, Keil JE, Cushman M, Psaty BM, Tracy RP, Tybjaerg-Hansen A, Nordestgaard BG, Frikke-Schmidt R, Giampaoli S, Palmieri L, Panico S, Vanuzzo D, Pilotto L, Simons L, McCallum J, Friedlander Y, Fowkes FG, Lee AJ, Smith FB, Taylor J, Guralnik J, Phillips C, Wallace R, Blazer D, Khaw KT, Jansson JH, Donfrancesco C, Salomaa V, Harald K, Jousilahti P, Vartiainen E, Woodward M, D'Agostino RB, Wolf PA, Vasan RS, Pencina MJ, Bladbjerg EM, Jorgensen T, Moller L, Jespersen J, Dankner R, Chetrit A, Lubin F, Rosengren A, Wilhelmsen L, Lappas G, Eriksson H, Bjorkelund C, Cremer P, Nagel D, Tilvis R, Strandberg T, Rodriguez B, Bouter LM, Heine RJ, Dekker JM, Nijpels G, Stehouwer CD, Rimm E, Pai J, Sato S, Iso H, Kitamura A, Noda H, Goldbourt U, Salomaa V, Salonen JT, Nyyssönen K, Tuomainen TP, Deeg D, Poppelaars JL, Meade T, Cooper J, Hedblad B, Berglund G, Engstrom G, Döring A, Koenig W, Meisinger C, Mraz W, Kuller L, Selmer R, Tverdal A, Nystad W, Gillum R, Mussolino M, Hankinson S, Manson J, De Stavola B, Knottenbelt C, Cooper JA, Bauer KA, Rosenberg RD, Sato S, Naito Y, Holme I, Nakagawa H, Miura H, Ducimetiere P, Jouven X, Crespo C, Garcia-Palmieri M, Amouyel P, Arveiler D, Evans A, Ferrieres J, Schulte H, Assmann G, Shepherd J, Packard C, Sattar N, Cantin B, Lamarche B, Després JP, Dagenais GR, Barrett-Connor E, Wingard D, Bettencourt R, Gudnason V, Aspelund T, Sigurdsson G, Thorsson B, Trevisan M, Witteman J, Kardys I, Breteler M, Hofman A, Tunstall-Pedoe H, Tavendale R, Lowe GD, Ben-Shlomo Y, Howard BV, Zhang Y, Best L, Umans J, Onat A, Meade TW, Njolstad I, Mathiesen E, Lochen ML, Wilsgaard T, Gaziano JM, Stampfer M, Ridker P, Ulmer H, Diem G, Concin H, Rodeghiero F, Tosetto A, Brunner E, Shipley M, Buring J, Cobbe SM, Ford I, Robertson M, He Y, Ibanez AM, Feskens EJ, Kromhout D, Collins R, Di Angelantonio E, Kaptoge S, Lewington S, Orfei L, Pennells L, Perry P, Ray K, Sarwar N, Scherman M, Thompson A, Watson S, Wensley F, White IR, Wood AM. The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol. 2007; 22(12):839-69.View Related Profiles.

Gaziano, J. Michael
Buring, Julie
Bauer, Kenneth Alan
Pencina, Michael
Wolf, Philip
D'Agostino, Ralph
Ramachandran, Vasan

PMID: 17876711

Govers-Riemslag JW, Smid M, Cooper JA, Bauer KA, Rosenberg RD, Hack CE, Hamulyak K, Spronk HM, Miller GJ, ten Cate H. The plasma kallikrein-kinin system and risk of cardiovascular disease in men. J Thromb Haemost. 2007 Sep; 5(9):1896-903. PMID: 17723129

Turpie AG, Bauer KA, Caprini JA, Comp PC, Gent M, Muntz JE. Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison. J Thromb Haemost. 2007 Sep; 5(9):1854-61. PMID: 17723125

Bauer KA. Targeted inhibition of coagulation: oral agents show promise in phase III trials. J Thromb Haemost. 2007 Nov; 5(11):2175-7. PMID: 17764539

Silverstein RL, Bauer KA, Cushman M, Esmon CT, Ershler WB, Tracy RP. Venous thrombosis in the elderly: more questions than answers. Blood. 2007 Nov 01; 110(9):3097-101. PMID: 17684155

Fisher WD, Eriksson BI, Bauer KA, Borris L, Dahl OE, Gent M, Haas S, Homering M, Huisman MV, Kakkar AK, Kälebo P, Kwong LM, Misselwitz F, Turpie AG. Rivaroxaban for thromboprophylaxis after orthopaedic surgery: pooled analysis of two studies. Thromb Haemost. 2007 Jun; 97(6):931-7. PMID: 17549294

Kocher O, Cirovic C, Malynn E, Rowland CM, Bare LA, Young BA, Henslee JG, Laffler TG, Huff JB, Kruskall MS, Wong G, Bauer KA. Obstetric complications in patients with hereditary thrombophilia identified using the LCx microparticle enzyme immunoassay: a controlled study of 5,000 patients. Am J Clin Pathol. 2007 Jan; 127(1):68-75. PMID: 17145624

Cushman M, Glynn RJ, Goldhaber SZ, Moll S, Bauer KA, Deitcher S, Shrivastava S, Ridker PM. Hormonal factors and risk of recurrent venous thrombosis: the prevention of recurrent venous thromboembolism trial. J Thromb Haemost. 2006 Oct; 4(10):2199-203. PMID: 16869933

Pollak ES, Russell TT, Ptashkin B, Smith-Whitley K, Camire RM, Bauer KA. Asymptomatic factor VII deficiency in African Americans. Am J Clin Pathol. 2006 Jul; 126(1):128-32. PMID: 16753603

Shrivastava S, Ridker PM, Glynn RJ, Goldhaber SZ, Moll S, Bounameaux H, Bauer KA, Kessler CM, Cushman M. D-dimer, factor VIII coagulant activity, low-intensity warfarin and the risk of recurrent venous thromboembolism. J Thromb Haemost. 2006 Jun; 4(6):1208-14. PMID: 16706961

Zwicker JI, Peyvandi F, Palla R, Lombardi R, Canciani MT, Cairo A, Ardissino D, Bernardinelli L, Bauer KA, Lawler J, Mannucci P. The thrombospondin-1 N700S polymorphism is associated with early myocardial infarction without altering von Willebrand factor multimer size. Blood. 2006 Aug 15; 108(4):1280-3. PMID: 16684956; PMCID: PMC1895875; DOI: 10.1182/blood-2006-04-015701;

Dezube BJ, Krown SE, Lee JY, Bauer KS, Aboulafia DM. Randomized phase II trial of matrix metalloproteinase inhibitor COL-3 in AIDS-related Kaposi's sarcoma: an AIDS Malignancy Consortium Study. J Clin Oncol. 2006 Mar 20; 24(9):1389-94. PMID: 16549833

Bauer KA. New anticoagulants: anti IIa vs anti Xa--is one better? J Thromb Thrombolysis. 2006 Feb; 21(1):67-72. PMID: 16475045

Bauer KA. New anticoagulants. Hematology Am Soc Hematol Educ Program. 2006; 450-6. PMID: 17124098

Ireland H, Konstantoulas CJ, Cooper JA, Hawe E, Humphries SE, Mather H, Goodall AH, Hogwood J, Juhan-Vague I, Yudkin JS, di Minno G, Margaglione M, Hamsten A, Miller GJ, Bauer KA, Kim YT, Stearns-Kurosawa DJ, Kurosawa S. EPCR Ser219Gly: elevated sEPCR, prothrombin F1+2, risk for coronary heart disease, and increased sEPCR shedding in vitro. Atherosclerosis. 2005 Dec; 183(2):283-92.View Related Profiles.

Stearns-Kurosawa, Deborah
Bauer, Kenneth Alan

PMID: 15921688

Turpie AG, Fisher WD, Bauer KA, Kwong LM, Irwin MW, Kälebo P, Misselwitz F, Gent M. BAY 59-7939: an oral, direct factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement. A phase II dose-ranging study. J Thromb Haemost. 2005 Nov; 3(11):2479-86. PMID: 16241946

Danesh J, Lewington S, Thompson SG, Lowe GD, Collins R, Kostis JB, Wilson AC, Folsom AR, Wu K, Benderly M, Goldbourt U, Willeit J, Kiechl S, Yarnell JW, Sweetnam PM, Elwood PC, Cushman M, Psaty BM, Tracy RP, Tybjaerg-Hansen A, Haverkate F, de Maat MP, Fowkes FG, Lee AJ, Smith FB, Salomaa V, Harald K, Rasi R, Vahtera E, Jousilahti P, Pekkanen J, D'Agostino R, Kannel WB, Wilson PW, Tofler G, Arocha-Piñango CL, Rodriguez-Larralde A, Nagy E, Mijares M, Espinosa R, Rodriquez-Roa E, Ryder E, Diez-Ewald MP, Campos G, Fernandez V, Torres E, Marchioli R, Valagussa F, Rosengren A, Wilhelmsen L, Lappas G, Eriksson H, Cremer P, Nagel D, Curb JD, Rodriguez B, Yano K, Salonen JT, Nyyssönen K, Tuomainen TP, Hedblad B, Lind P, Loewel H, Koenig W, Meade TW, Cooper JA, De Stavola B, Knottenbelt C, Miller GJ, Cooper JA, Bauer KA, Rosenberg RD, Sato S, Kitamura A, Naito Y, Palosuo T, Ducimetiere P, Amouyel P, Arveiler D, Evans AE, Ferrieres J, Juhan-Vague I, Bingham A, Schulte H, Assmann G, Cantin B, Lamarche B, Després JP, Dagenais GR, Tunstall-Pedoe H, Woodward M, Ben-Shlomo Y, Davey Smith G, Palmieri V, Yeh JL, Rudnicka A, Ridker P, Rodeghiero F, Tosetto A, Shepherd J, Ford I, Robertson M, Brunner E, Shipley M, Feskens EJ, Kromhout D, Dickinson A, Ireland B, Juzwishin K, Kaptoge S, Lewington S, Memon A, Sarwar N, Walker M, Wheeler J, White I, Wood A. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA. 2005 Oct 12; 294(14):1799-809.View Related Profiles.

Bauer, Kenneth Alan
D'Agostino, Ralph

PMID: 16219884

Feinbloom D, Bauer KA. Assessment of hemostatic risk factors in predicting arterial thrombotic events. Arterioscler Thromb Vasc Biol. 2005 Oct; 25(10):2043-53. PMID: 16100033

Miller GJ, Bauer KA, Howarth DJ, Cooper JA, Humphries SE, Rosenberg RD. Increased incidence of neoplasia of the digestive tract in men with persistent activation of the coagulant pathway. J Thromb Haemost. 2004 Dec; 2(12):2107-14. PMID: 15613014

Zwicker JI, Uhl L, Huang WY, Shaz BH, Bauer KA. Thrombosis and ELISA optical density values in hospitalized patients with heparin-induced thrombocytopenia. J Thromb Haemost. 2004 Dec; 2(12):2133-7. PMID: 15613017

Bauer KA. Role of thrombophilia in deciding on the duration of anticoagulation. Semin Thromb Hemost. 2004 Dec; 30(6):633-7. PMID: 15630669

Turpie AG, Eriksson BI, Bauer KA, Lassen MR. Fondaparinux. J Am Acad Orthop Surg. 2004 Nov-Dec; 12(6):371-5. PMID: 15615502

Huang WY, Kruskall MS, Bauer KA, Uhl L, Shaz BH. The use of recombinant activated factor VII in three patients with central nervous system hemorrhages associated with factor VII deficiency. Transfusion. 2004 Nov; 44(11):1562-6. PMID: 15504160

Lee AY, Gent M, Julian JA, Bauer KA, Eriksson BI, Lassen MR, Turpie AG. Bilateral vs. ipsilateral venography as the primary efficacy outcome measure in thromboprophylaxis clinical trials: a systematic review. J Thromb Haemost. 2004 Oct; 2(10):1752-9. PMID: 15456486

Bauer KA. Low intensity warfarin: is it clinically useful in venous thromboembolism management? Br J Haematol. 2004 Oct; 127(2):155-8. PMID: 15461620

Turpie AG, Bauer KA, Eriksson BI, Lassen MR. Superiority of fondaparinux over enoxaparin in preventing venous thromboembolism in major orthopedic surgery using different efficacy end points. Chest. 2004 Aug; 126(2):501-8. PMID: 15302737

Pantanowitz L, Bauer K, Tefs K, Schuster V, Balogh K, Pilch BZ, Adcock D, Cirovic C, Kocher O. Ligneous (pseudomembranous) inflammation involving the female genital tract associated with type-1 plasminogen deficiency. Int J Gynecol Pathol. 2004 Jul; 23(3):292-5. PMID: 15213608

Bauer KA. Fondaparinux: a new synthetic and selective inhibitor of Factor Xa. Best Pract Res Clin Haematol. 2004 Mar; 17(1):89-104. PMID: 15171960

Vossen CY, Hasstedt SJ, Rosendaal FR, Callas PW, Bauer KA, Broze GJ, Hoogendoorn H, Long GL, Scott BT, Bovill EG. Heritability of plasma concentrations of clotting factors and measures of a prethrombotic state in a protein C-deficient family. J Thromb Haemost. 2004 Feb; 2(2):242-7. PMID: 14995985

Turpie AG, Eriksson BI, Bauer KA, Lassen MR. New pentasaccharides for the prophylaxis of venous thromboembolism: clinical studies. Chest. 2003 Dec; 124(6 Suppl):371S-378S. PMID: 14668420

Bauer KA. New pentasaccharides for prophylaxis of deep vein thrombosis: pharmacology. Chest. 2003 Dec; 124(6 Suppl):364S-370S. PMID: 14668419

Turpie AG, Bauer KA, Eriksson BI, Lassen MR. Fondaparinux and prevention of venous thromboembolism after orthopaedic surgery. Lancet. 2003 Nov 08; 362(9395):1582-3. PMID: 14615120

Carew JA, Basso F, Miller GJ, Hawe E, Jackson AA, Humphries SE, Bauer KA. A functional haplotype in the 5' flanking region of the factor VII gene is associated with an increased risk of coronary heart disease. J Thromb Haemost. 2003 Oct; 1(10):2179-85. PMID: 14521602

Turpie AG, Eriksson BI, Lassen MR, Bauer KA. Fondaparinux, the first selective factor Xa inhibitor. Curr Opin Hematol. 2003 Sep; 10(5):327-32. PMID: 12913785

Turpie A, Bauer K, Eriksson B, Lassen M. Efficacy and safety of fondaparinux in major orthopedic surgery according to the timing of its first administration. Thromb Haemost. 2003 Aug; 90(2):364-6. PMID: 12888887

Ardissino D, Merlini PA, Bauer KA, Galvani M, Ottani F, Franchi F, Bertocchi F, Rosenberg RD, Mannucci PM. Coagulation activation and long-term outcome in acute coronary syndromes. Blood. 2003 Oct 15; 102(8):2731-5. PMID: 12843003

Bauer KA. Management of thrombophilia. J Thromb Haemost. 2003 Jul; 1(7):1429-34. PMID: 12871277

Carew JA, Jackson AA, Bauer KA. ARP1 interacts with the 5' flanking region of the coagulation factor VII gene. J Thromb Haemost. 2003 Jun; 1(6):1220-7. PMID: 12871323

Konkle BA, Bauer KA, Weinstein R, Greist A, Holmes HE, Bonfiglio J. Use of recombinant human antithrombin in patients with congenital antithrombin deficiency undergoing surgical procedures. Transfusion. 2003 Mar; 43(3):390-4. PMID: 12675726

Ridker PM, Goldhaber SZ, Danielson E, Rosenberg Y, Eby CS, Deitcher SR, Cushman M, Moll S, Kessler CM, Elliott CG, Paulson R, Wong T, Bauer KA, Schwartz BA, Miletich JP, Bounameaux H, Glynn RJ. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med. 2003 Apr 10; 348(15):1425-34. PMID: 12601075

Eriksson BI, Bauer KA, Lassen MR, Turpie AG. Influence of the duration of fondaparinux (Arixtra) prophylaxis in preventing venous thromboembolism following major orthopedic surgery. J Thromb Haemost. 2003 Feb; 1(2):383-4. PMID: 12871516

Bauer KA. Fondaparinux: basic properties and efficacy and safety in venous thromboembolism prophylaxis. Am J Orthop (Belle Mead NJ). 2002 Nov; 31(11 Suppl):4-10. PMID: 12463577

Peyvandi F, De Cristofaro R, Akhavan S, Carew JA, Landolfi R, Bauer KA, Mannucci PM. Two naturally occurring mutations on FVII gene (S363I-W364C) altering intrinsic catalytic activity. Thromb Haemost. 2002 Nov; 88(5):750-5. PMID: 12428089

Press RD, Bauer KA, Kujovich JL, Heit JA. Clinical utility of factor V leiden (R506Q) testing for the diagnosis and management of thromboembolic disorders. Arch Pathol Lab Med. 2002 Nov; 126(11):1304-18. PMID: 12421138

Moons AH, Peters RJ, Cate Ht, Bauer KA, Vlasuk GP, Büller HR, Levi M. Recombinant nematode anticoagulant protein c2, a novel inhibitor of tissue factor-factor VIIa activity, abrogates endotoxin-induced coagulation in chimpanzees. Thromb Haemost. 2002 Oct; 88(4):627-31. PMID: 12362234

Turpie AG, Bauer KA, Eriksson BI, Lassen MR. Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies. Arch Intern Med. 2002 Sep 09; 162(16):1833-40. PMID: 12196081

Bauer KA, Eriksson BI, Lassen MR, Turpie AG. Factor Xa inhibition in the prevention of venous thromboembolism and treatment of patients with venous thromboembolism. Curr Opin Pulm Med. 2002 Sep; 8(5):398-404. PMID: 12172443

Cella G, Randi ML, Sbarai A, Bauer KA, Barzega S, Rosenberg RD. Factor IX activation peptide and soluble selectins in patients with chronic myeloproliferative disorders. Haematologica. 2002 Jun; 87(6):671-2. PMID: 12031932

Bauer KA. Hormone replacement therapy and the factor V Leiden mutation. Arterioscler Thromb Vasc Biol. 2002 Jun 01; 22(6):879-80. PMID: 12067891

Bauer KA. Selective inhibition of coagulation factors: advances in antithrombotic therapy. Semin Thromb Hemost. 2002 Jun; 28 Suppl 2:15-24. PMID: 12073176

Turpie AG, Bauer KA, Eriksson BI, Lassen MR. Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial. Lancet. 2002 May 18; 359(9319):1721-6. PMID: 12049860

Lassen MR, Bauer KA, Eriksson BI, Turpie AG. Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison. Lancet. 2002 May 18; 359(9319):1715-20. PMID: 12049858

Miller GJ, Bauer KA, Howarth DJ, Mitchell JP, Cooper JA. Does inflammatory proteolytic activity contribute to the increased factor IX activation peptide in men at high risk of coronary heart disease? A preliminary study. Thromb Haemost. 2002 Mar; 87(3):415-20. PMID: 11916072

Turpie AG, Eriksson BI, Lassen MR, Bauer KA. A meta-analysis of fondaparinux versus enoxaparin in the prevention of venous thromboembolism after major orthopaedic surgery. J South Orthop Assoc. 2002; 11(4):182-8. PMID: 12597061

Bauer KA, Eriksson BI, Lassen MR, Turpie AG. A new antithrombotic strategy, the selective inhibition of coagulation factors, and its importance to the orthopedic specialist. J South Orthop Assoc. 2002; 11(4):197-202. PMID: 12597063

Bauer KA, Rosendaal FR, Heit JA. Hypercoagulability: too many tests, too much conflicting data. Hematology Am Soc Hematol Educ Program. 2002; 353-68. PMID: 12446432

Bauer KA, Hawkins DW, Peters PC, Petitou M, Herbert JM, van Boeckel CA, Meuleman DG. Fondaparinux, a synthetic pentasaccharide: the first in a new class of antithrombotic agents - the selective factor Xa inhibitors. Cardiovasc Drug Rev. 2002; 20(1):37-52. PMID: 12070533

Gilchrist A, Solomon N, Erickson D, Sikand A, Bauer KA, Kruskall MS, Kocher O. Automated detection of the G20210A prothrombin mutation using the LCx microparticle enzyme immunoassay. Clin Chim Acta. 2001 Dec; 314(1-2):249-54. PMID: 11718704

Ardissino D, Merlini PA, Bauer KA, Bramucci E, Ferrario M, Coppola R, Fetiveau R, Lucreziotti S, Rosenberg RD, Mannucci PM. Thrombogenic potential of human coronary atherosclerotic plaques. Blood. 2001 Nov 01; 98(9):2726-9. PMID: 11675344

Eriksson BI, Bauer KA, Lassen MR, Turpie AG. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery. N Engl J Med. 2001 Nov 01; 345(18):1298-304. PMID: 11794148

Bauer KA, Eriksson BI, Lassen MR, Turpie AG. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery. N Engl J Med. 2001 Nov 01; 345(18):1305-10. PMID: 11794149

Bauer KA. Fondaparinux sodium: a selective inhibitor of factor Xa. Am J Health Syst Pharm. 2001 Nov 01; 58 Suppl 2:S14-7. PMID: 11715834

Bauer KA. The thrombophilias: well-defined risk factors with uncertain therapeutic implications. Ann Intern Med. 2001 Sep 04; 135(5):367-73. PMID: 11529700

Friederich PW, Levi M, Bauer KA, Vlasuk GP, Rote WE, Breederveld D, Keller T, Spataro M, Barzegar S, Büller HR. Ability of recombinant factor VIIa to generate thrombin during inhibition of tissue factor in human subjects. Circulation. 2001 May 29; 103(21):2555-9. PMID: 11382723

Bauer KA. Conventional fibrinolytic assays for the evaluation of patients with venous thrombosis: don't bother. Thromb Haemost. 2001 Mar; 85(3):377-8. PMID: 11307800

Peyvandi F, Carew JA, Perry DJ, Hunault M, Khanduri U, Perkins SJ, Mannucci PM, Bauer KA. Abnormal secretion and function of recombinant human factor VII as the result of modification to a calcium binding site caused by a 15-base pair insertion in the F7 gene. Blood. 2001 Feb 15; 97(4):960-5. PMID: 11159523

Carew JA, Pollak ES, Lopaciuk S, Bauer KA. A new mutation in the HNF4 binding region of the factor VII promoter in a patient with severe factor VII deficiency. Blood. 2000 Dec 15; 96(13):4370-2. PMID: 11110717

Cooper JA, Miller GJ, Bauer KA, Morrissey JH, Meade TW, Howarth DJ, Barzegar S, Mitchell JP, Rosenberg RD. Comparison of novel hemostatic factors and conventional risk factors for prediction of coronary heart disease. Circulation. 2000 Dec 05; 102(23):2816-22. PMID: 11104738

Minnema MC, Peters RJ, de Winter R, Lubbers YP, Barzegar S, Bauer KA, Rosenberg RD, Hack CE, ten Cate H. Activation of clotting factors XI and IX in patients with acute myocardial infarction. Arterioscler Thromb Vasc Biol. 2000 Nov; 20(11):2489-93. PMID: 11073857

Merlini PA, Ardissino D, Rosenberg RD, Colombi E, Agricola P, Oltrona L, Ottani F, Galvani M, Bauer KA, Bottasso B, Bertocchi F, Mannucci PM. In vivo thrombin generation and activity during and after intravenous infusion of heparin or recombinant hirudin in patients with unstable angina pectoris. Arterioscler Thromb Vasc Biol. 2000 Sep; 20(9):2162-6. PMID: 10978264

Bauer KA, Humphries S, Smillie B, Li L, Cooper JA, Barzegar S, Rosenberg RD, Miller GJ. Prothrombin activation is increased among asymptomatic carriers of the prothrombin G20210A and factor V Arg506Gln mutations. Thromb Haemost. 2000 Sep; 84(3):396-400. PMID: 11019961

Bovill EG, Hasstedt SJ, Callas PW, Valliere JE, Scott BT, Bauer KA, Long GL. The G20210A prothrombin polymorphism is not associated with increased thromboembolic risk in a large protein C deficient kindred. Thromb Haemost. 2000 Mar; 83(3):366-70. PMID: 10744139

Hunault M, Bauer KA. Recombinant factor VIIa for the treatment of congenital factor VII deficiency. Semin Thromb Hemost. 2000; 26(4):401-5. PMID: 11092215

Bauer KA. Activation markers of coagulation. Baillieres Best Pract Res Clin Haematol. 1999 Sep; 12(3):387-406. PMID: 10856977

Hunault M, Arbini AA, Carew JA, Bauer KA. Mechanism underlying factor VII deficiency in Jewish populations with the Ala244Val mutation. Br J Haematol. 1999 Jun; 105(4):1101-8. PMID: 10554827

Xu X, Bauer KA, Griffin JH. Two multiplex PCR-based DNA assays for the thrombosis risk factors prothrombin G20210A and coagulation factor V G1691A polymorphisms. Thromb Res. 1999 Mar 15; 93(6):265-9. PMID: 10093967

Wulf GM, Van Deerlin VM, Leonard DG, Bauer KA. Thrombosis in a patient with combined homozygosity for the factor V Leiden mutation and a mutation in the 3'-untranslated region of the prothrombin gene. Blood Coagul Fibrinolysis. 1999 Mar; 10(2):107-10. PMID: 10192660

Hunault M, Arbini AA, Carew JA, Peyvandi F, Bauer KA. Characterization of two naturally occurring mutations in the second epidermal growth factor-like domain of factor VII. Blood. 1999 Feb 15; 93(4):1237-44. PMID: 9949166

Hunault M, Marsh-Scott C, Jou C, Marshall R, Scheffel C, Fiore LD, Bauer KA, Mitchell MJ. Automated detection of the factor V Leiden mutation using the LCx microparticle enzyme immunoassay. Clin Chem. 1999 Jan; 45(1):41-6.View Related Profiles.

Bauer, Kenneth Alan
Fiore, Louis

PMID: 9895336

Carew JA, Pollak ES, High KA, Bauer KA. Severe factor VII deficiency due to a mutation disrupting an Sp1 binding site in the factor VII promoter. Blood. 1998 Sep 01; 92(5):1639-45. PMID: 9716591

Miller GJ, Bauer KA, Cooper JA, Rosenberg RD. Activation of the coagulant pathway in cigarette smokers. Thromb Haemost. 1998 Mar; 79(3):549-53. PMID: 9531038

Hunault M, Arbini AA, Lopaciuk S, Carew JA, Bauer KA. The Arg353Gln polymorphism reduces the level of coagulation factor VII. In vivo and in vitro studies. Arterioscler Thromb Vasc Biol. 1997 Nov; 17(11):2825-9. PMID: 9409261

Merlini PA, Ardissino D, Bauer KA, Oltrona L, Pezzano A, Bottasso B, Rosenberg RD, Mannucci PM. Persistent thrombin generation during heparin therapy in patients with acute coronary syndromes. Arterioscler Thromb Vasc Biol. 1997 Jul; 17(7):1325-30. PMID: 9261263

Bauer KA. Activation of the factor VII-tissue factor pathway. Thromb Haemost. 1997 Jul; 78(1):108-11. PMID: 9198137

Arbini AA, Pollak ES, Bayleran JK, High KA, Bauer KA. Severe factor VII deficiency due to a mutation disrupting a hepatocyte nuclear factor 4 binding site in the factor VII promoter. Blood. 1997 Jan 01; 89(1):176-82. PMID: 8978290

Lane DA, Mannucci PM, Bauer KA, Bertina RM, Bochkov NP, Boulyjenkov V, Chandy M, Dahlbäck B, Ginter EK, Miletich JP, Rosendaal FR, Seligsohn U. Inherited thrombophilia: Part 2. Thromb Haemost. 1996 Dec; 76(6):824-34. PMID: 8971998

Lane DA, Mannucci PM, Bauer KA, Bertina RM, Bochkov NP, Boulyjenkov V, Chandy M, Dahlbäck B, Ginter EK, Miletich JP, Rosendaal FR, Seligsohn U. Inherited thrombophilia: Part 1. Thromb Haemost. 1996 Nov; 76(5):651-62. PMID: 8950768

Arbini AA, Mannucci M, Bauer KA. A Thr359Met mutation in factor VII of a patient with a hereditary deficiency causes defective secretion of the molecule. Blood. 1996 Jun 15; 87(12):5085-94. PMID: 8652821

Miller GJ, Bauer KA, Barzegar S, Cooper JA, Rosenberg RD. Increased activation of the haemostatic system in men at high risk of fatal coronary heart disease. Thromb Haemost. 1996 May; 75(5):767-71. PMID: 8725721

ten Cate H, Biemond BJ, Levi M, Wuillemin WA, Bauer KA, Barzegar S, Buller HR, Hack CE, ten Cate JW, Rosenberg RD. Factor XIa induced activation of the intrinsic cascade in vivo. Thromb Haemost. 1996 Mar; 75(3):445-9. PMID: 8701405

van Boven HH, Reitsma PH, Rosendaal FR, Bayston TA, Chowdhury V, Bauer KA, Scharrer I, Conard J, Lane DA. Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency. Thromb Haemost. 1996 Mar; 75(3):417-21. PMID: 8701400

Bauer KA, Eichinger S, Mannucci PM, Rosenberg RD. Determinants of coagulation activation in humans. Haemostasis. 1996; 26 Suppl 1:72-5. PMID: 8904177

Bauer KA. Treatment of factor VII deficiency with recombinant factor VIIa. Haemostasis. 1996; 26 Suppl 1:155-8. PMID: 8904192

Merlini PA, Ardissino D, Bauer KA, Oltrona L, Spinola A, Diotallevi P, Rosenberg RD, Mannucci PM. Activation of the hemostatic mechanism during thrombolysis in patients with unstable angina pectoris. Blood. 1995 Nov 01; 86(9):3327-32. PMID: 7579435

Arbini AA, Mannucci PM, Bauer KA. Low prevalence of the factor V Leiden mutation among "severe" hemophiliacs with a "milder" bleeding diathesis. Thromb Haemost. 1995 Nov; 74(5):1255-8. PMID: 8607105

Eichinger S, Mannucci PM, Tradati F, Arbini AA, Rosenberg RD, Bauer KA. Determinants of plasma factor VIIa levels in humans. Blood. 1995 Oct 15; 86(8):3021-5. PMID: 7579395

Bauer KA. Management of patients with hereditary defects predisposing to thrombosis including pregnant women. Thromb Haemost. 1995 Jul; 74(1):94-100. PMID: 8578533

Mari D, Mannucci PM, Coppola R, Bottasso B, Bauer KA, Rosenberg RD. Hypercoagulability in centenarians: the paradox of successful aging. Blood. 1995 Jun 01; 85(11):3144-9. PMID: 7756646

Miller GJ, Bauer KA, Barzegar S, Foley AJ, Mitchell JP, Cooper JA, Rosenberg RD. The effects of quality and timing of venepuncture on markers of blood coagulation in healthy middle-aged men. Thromb Haemost. 1995 Jan; 73(1):82-6. PMID: 7740501

Merlini PA, Bauer KA, Oltrona L, Ardissino D, Spinola A, Cattaneo M, Broccolino M, Mannucci PM, Rosenberg RD. Thrombin generation and activity during thrombolysis and concomitant heparin therapy in patients with acute myocardial infarction. J Am Coll Cardiol. 1995 Jan; 25(1):203-9. PMID: 7798503

Greengard JS, Eichinger S, Griffin JH, Bauer KA. Brief report: variability of thrombosis among homozygous siblings with resistance to activated protein C due to an Arg-->Gln mutation in the gene for factor V. N Engl J Med. 1994 Dec 08; 331(23):1559-62. PMID: 7969326

Arbini AA, Bodkin D, Lopaciuk S, Bauer KA. Molecular analysis of Polish patients with factor VII deficiency. Blood. 1994 Oct 01; 84(7):2214-20. PMID: 7919338

Bauer KA. New markers for in vivo coagulation. Curr Opin Hematol. 1994 Sep; 1(5):341-6. PMID: 9371303

Bauer KA, Rosenberg RD. Activation markers of coagulation. Baillieres Clin Haematol. 1994 Sep; 7(3):523-40. PMID: 7841599

Mannucci PM, Bauer KA, Santagostino E, Faioni E, Barzegar S, Coppola R, Rosenberg RD. Activation of the coagulation cascade after infusion of a factor XI concentrate in congenitally deficient patients. Blood. 1994 Aug 15; 84(4):1314-9. PMID: 8049446

Merlini PA, Bauer KA, Oltrona L, Ardissino D, Cattaneo M, Belli C, Mannucci PM, Rosenberg RD. Persistent activation of coagulation mechanism in unstable angina and myocardial infarction. Circulation. 1994 Jul; 90(1):61-8. PMID: 8026047

Santagostino E, Mannucci PM, Gringeri A, Tagariello G, Baudo F, Bauer KA, Rosenberg RD. Markers of hypercoagulability in patients with hemophilia B given repeated, large doses of factor IX concentrates during and after surgery. Thromb Haemost. 1994 Jun; 71(6):737-40. PMID: 7974341

Levi M, ten Cate H, Bauer KA, van der Poll T, Edgington TS, Büller HR, van Deventer SJ, Hack CE, ten Cate JW, Rosenberg RD. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. J Clin Invest. 1994 Jan; 93(1):114-20. PMID: 8282778; PMCID: PMC293743

ten Cate H, Bauer KA, Levi M, Edgington TS, Sublett RD, Barzegar S, Kass BL, Rosenberg RD. The activation of factor X and prothrombin by recombinant factor VIIa in vivo is mediated by tissue factor. J Clin Invest. 1993 Sep; 92(3):1207-12. PMID: 8376580; PMCID: PMC288259

Kistler JP, Singer DE, Millenson MM, Bauer KA, Gress DR, Barzegar S, Hughes RA, Sheehan MA, Maraventano SW, Oertel LB, et al. Effect of low-intensity warfarin anticoagulation on level of activity of the hemostatic system in patients with atrial fibrillation. BAATAF Investigators. Stroke. 1993 Sep; 24(9):1360-5. PMID: 8362431

Conard J, Bauer KA, Gruber A, Griffin JH, Schwarz HP, Horellou MH, Samama MM, Rosenberg RD. Normalization of markers of coagulation activation with a purified protein C concentrate in adults with homozygous protein C deficiency. Blood. 1993 Aug 15; 82(4):1159-64. PMID: 8353282

Schramm W, Spannagl M, Bauer KA, Rosenberg RD, Birkner B, Linnau Y, Schwarz HP. Treatment of coumarin-induced skin necrosis with a monoclonal antibody purified protein C concentrate. Arch Dermatol. 1993 Jun; 129(6):753-6. PMID: 8507079

Rosenberg RD, Bauer KA. Prothrombin activation fragment assay. Clin Chem. 1993 Apr; 39(4):559-60. PMID: 8472348

Bauer KA. Laboratory markers of coagulation activation. Arch Pathol Lab Med. 1993 Jan; 117(1):71-7. PMID: 8418767

Caine YG, Bauer KA, Barzegar S, ten Cate H, Sacks FM, Walsh BW, Schiff I, Rosenberg RD. Coagulation activation following estrogen administration to postmenopausal women. Thromb Haemost. 1992 Oct 05; 68(4):392-5. PMID: 1333098

Rosenberg RD, Bauer KA. Does a prethrombotic state exist? If so, what is it? Am J Clin Nutr. 1992 10; 56(4 Suppl):787S-788S. PMID: 1414980

Wilkes HC, Meade TW, Barzegar S, Foley AJ, Hughes LO, Bauer KA, Rosenberg RD, Miller GJ. Gemfibrozil reduces plasma prothrombin fragment F1 + 2 concentration, a marker of coagulability, in patients with coronary heart disease. Thromb Haemost. 1992 May 04; 67(5):503-6. PMID: 1519208

Bauer KA, Mannucci PM, Gringeri A, Tradati F, Barzegar S, Kass BL, ten Cate H, Kestin AS, Brettler DB, Rosenberg RD. Factor IXa-factor VIIIa-cell surface complex does not contribute to the basal activation of the coagulation mechanism in vivo. Blood. 1992 Apr 15; 79(8):2039-47. PMID: 1562731

Millenson MM, Bauer KA, Kistler JP, Barzegar S, Tulin L, Rosenberg RD. Monitoring "mini-intensity" anticoagulation with warfarin: comparison of the prothrombin time using a sensitive thromboplastin with prothrombin fragment F1+2 levels. Blood. 1992 Apr 15; 79(8):2034-8. PMID: 1562730

Mannucci PM, Bauer KA, Gringeri A, Barzegar S, Santagostino E, Tradati FC, Rosenberg RD. No activation of the common pathway of the coagulation cascade after a highly purified factor IX concentrate. Br J Haematol. 1991 Dec; 79(4):606-11. PMID: 1772782

Miller GJ, Wilkes HC, Meade TW, Bauer KA, Barzegar S, Rosenberg RD. Haemostatic changes that constitute the hypercoagulable state. Lancet. 1991 Oct 26; 338(8774):1079. PMID: 1681380

Lee MH, Kaczmarek E, Chin DT, Oda A, McIntosh S, Bauer KA, Clyne LP, McDonagh J. Fibrinogen Ledyard (A alpha Arg16----Cys): biochemical and physiologic characterization. Blood. 1991 Oct 01; 78(7):1744-52. PMID: 1912564

Bauer KA, Barzegar S, Rosenberg RD. Influence of anticoagulants used for blood collection on plasma prothrombin fragment F1 + 2 measurements. Thromb Res. 1991 Sep 15; 63(6):617-28. PMID: 1780806

Bauer KA, Rosenberg RD. Role of antithrombin III as a regulator of in vivo coagulation. Semin Hematol. 1991 Jan; 28(1):10-8. PMID: 2017686

Mannucci PM, Bauer KA, Gringeri A, Barzegar S, Bottasso B, Simoni L, Rosenberg RD. Thrombin generation is not increased in the blood of hemophilia B patients after the infusion of a purified factor IX concentrate. Blood. 1990 Dec 15; 76(12):2540-5. PMID: 2265248

van Hinsbergh VW, Bauer KA, Kooistra T, Kluft C, Dooijewaard G, Sherman ML, Nieuwenhuizen W. Progress of fibrinolysis during tumor necrosis factor infusions in humans. Concomitant increase in tissue-type plasminogen activator, plasminogen activator inhibitor type-1, and fibrin(ogen) degradation products. Blood. 1990 Dec 01; 76(11):2284-9. PMID: 1701665

Bauer KA, Kass BL, ten Cate H, Hawiger JJ, Rosenberg RD. Factor IX is activated in vivo by the tissue factor mechanism. Blood. 1990 Aug 15; 76(4):731-6. PMID: 2383653

van der Poll T, Büller HR, ten Cate H, Wortel CH, Bauer KA, van Deventer SJ, Hack CE, Sauerwein HP, Rosenberg RD, ten Cate JW. Activation of coagulation after administration of tumor necrosis factor to normal subjects. N Engl J Med. 1990 Jun 07; 322(23):1622-7. PMID: 2188129

Bauer KA, Kass BL, ten Cate H, Bednarek MA, Hawiger JJ, Rosenberg RD. Detection of factor X activation in humans. Blood. 1989 Nov 01; 74(6):2007-15. PMID: 2804345

Schwartz RS, Bauer KA, Rosenberg RD, Kavanaugh EJ, Davies DC, Bogdanoff DA. Clinical experience with antithrombin III concentrate in treatment of congenital and acquired deficiency of antithrombin. The Antithrombin III Study Group. Am J Med. 1989 Sep 11; 87(3B):53S-60S. PMID: 2679072

Bauer KA, Rosenberg RD. Congenital antithrombin III deficiency: insights into the pathogenesis of the hypercoagulable state and its management using markers of hemostatic system activation. Am J Med. 1989 Sep 11; 87(3B):39S-43S. PMID: 2679069

Walker PA, Bauer KA, McDonagh J. A simple, automated functional assay for protein C. Am J Clin Pathol. 1989 Aug; 92(2):210-3. PMID: 2756936

Bauer KA, ten Cate H, Barzegar S, Spriggs DR, Sherman ML, Rosenberg RD. Tumor necrosis factor infusions have a procoagulant effect on the hemostatic mechanism of humans. Blood. 1989 Jul; 74(1):165-72. PMID: 2752108

Bovill EG, Bauer KA, Dickerman JD, Callas P, West B. The clinical spectrum of heterozygous protein C deficiency in a large New England kindred. Blood. 1989 Feb 15; 73(3):712-7. PMID: 2521802

Bauer KA, Broekmans AW, Bertina RM, Conard J, Horellou MH, Samama MM, Rosenberg RD. Hemostatic enzyme generation in the blood of patients with hereditary protein C deficiency. Blood. 1988 May; 71(5):1418-26. PMID: 2965928

Conway EM, Bauer KA, Barzegar S, Rosenberg RD. Suppression of hemostatic system activation by oral anticoagulants in the blood of patients with thrombotic diatheses. J Clin Invest. 1987 Dec; 80(6):1535-44. PMID: 3680513; PMCID: PMC442421

Bauer KA, Weiss LM, Sparrow D, Vokonas PS, Rosenberg RD. Aging-associated changes in indices of thrombin generation and protein C activation in humans. Normative Aging Study. J Clin Invest. 1987 Dec; 80(6):1527-34.View Related Profiles.

Sparrow, David
Bauer, Kenneth Alan
Vokonas, Pantel

PMID: 2824564; PMCID: PMC442420

Conway EM, Lau HK, Bauer KA, Rosenberg RD. Development of a radioimmunoassay for quantitating prethrombin 2 in human plasma. J Lab Clin Med. 1987 Nov; 110(5):567-75. PMID: 3668358

Bauer KA, Rosenberg RD. The pathophysiology of the prethrombotic state in humans: insights gained from studies using markers of hemostatic system activation. Blood. 1987 Aug; 70(2):343-50. PMID: 3607275

Rosenberg RD, Bauer KA. Thrombosis in inherited deficiencies of antithrombin, protein C, and protein S. Hum Pathol. 1987 Mar; 18(3):253-62. PMID: 2950042

Rosenberg RD, Bauer KA. New insights into hypercoagulable states. Hosp Pract (Off Ed). 1986 Mar 15; 21(3):131-8, 143, 147. PMID: 3081542

Bauer KA, Goodman TL, Kass BL, Rosenberg RD. Elevated factor Xa activity in the blood of asymptomatic patients with congenital antithrombin deficiency. J Clin Invest. 1985 Aug; 76(2):826-36. PMID: 3875633; PMCID: PMC423911

Rosenberg RD, Bauer KA, Marcum JA. Protease inhibitors of human plasma. Antithrombin-III. "The heparin-antithrombin system". J Med. 1985; 16(1-3):351-416. PMID: 3915998

Bauer KA. The role of the laboratory in preventing and diagnosing arterial or veinal thrombotic accidents, and in monitoring their treatment. Ann Biol Clin (Paris). 1985; 43(4):451-4. PMID: 4091308

Bauer KA, Kass BL, Beeler DL, Rosenberg RD. Detection of protein C activation in humans. J Clin Invest. 1984 Dec; 74(6):2033-41. PMID: 6549015; PMCID: PMC425392

Bauer KA, Rosenberg RD. Thrombin generation in acute promyelocytic leukemia. Blood. 1984 Oct; 64(4):791-6. PMID: 6592007

Bauer KA, Ashenhurst JB, Chediak J, Rosenberg RD. Antithrombin "Chicago": a functionally abnormal molecule with increased heparin affinity causing familial thrombophilia. Blood. 1983 Dec; 62(6):1242-50. PMID: 6640109

Prochownik EV, Antonarakis S, Bauer KA, Rosenberg RD, Fearon ER, Orkin SH. Molecular heterogeneity of inherited antithrombin III deficiency. N Engl J Med. 1983 Jun 30; 308(26):1549-52. PMID: 6304514

Bauer KA, Teitel JM, Rosenberg RD. L-asparaginase induced antithrombin III deficiency: evidence against the production of a hypercoagulable state. Thromb Res. 1983 Feb 15; 29(4):437-42. PMID: 6857592

Stead NW, Bauer KA, Kinney TR, Lewis JG, Campbell EE, Shifman MA, Rosenberg RD, Pizzo SV. Venous thrombosis in a family with defective release of vascular plasminogen activator and elevated plasma factor VIII/von Willebrand's factor. Am J Med. 1983 Jan; 74(1):33-9. PMID: 6401391

Teitel JM, Bauer KA, Lau HK, Rosenberg RD. Studies of the prothrombin activation pathway utilizing radioimmunoassays for the F2/F1 + 2 fragment and thrombin--antithrombin complex. Blood. 1982 May; 59(5):1086-97. PMID: 7074214

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 208 publications over 43 distinct years, with a maximum of 16 publications in 2002

Bar chart showing 208 publications over 43 distinct years, with a maximum of 16 publications in 2002

Year	Publications
1982	1
1983	4
1984	2
1985	3
1986	1
1987	5
1988	1
1989	6
1990	4
1991	5
1992	5
1993	6
1994	8
1995	7
1996	8
1997	4
1998	2
1999	6
2000	7
2001	9
2002	16
2003	12
2004	11
2005	4
2006	7
2007	8
2008	6
2009	6
2010	6
2011	3
2012	3
2013	5
2014	1
2015	3
2016	1
2017	4
2018	1
2019	3
2020	9
2021	1
2022	2
2023	1
2024	1

Contact for Mentoring:

72 E. Concord Street
Boston MA 02118
Google Map

Download vCard

Bauer's Networks

Click the "See All" links for more information and interactive visualizations

Concepts

See all (586) concept(s)

Co-Authors

See all (10) people

Similar People

See all (60) people

Same Department

Search Department